Invesco SandP 500 Concentrated QVM ETF (QVMT)
Live price chart, market sentiment, and community perspectives for Invesco SandP 500 Concentrated QVM ETF (AMEX: QVMT).
Live price chart, market sentiment, and community perspectives for Invesco SandP 500 Concentrated QVM ETF (AMEX: QVMT).
On our desk, we're watching the transition from the old Enhanced Value mandate to the new SandP 500 Quality, Value and Momentum Multi-factor Index very closely. At around $134 million in total assets, QVMT is still quite small, but its low expense ratio of 0.13% to 0.15% makes it an efficient instrument for tactical factor tilts. The fact that it overlaps with IVV by just 15% gives portfolio constructors a genuine way to decouple from market-cap weighting without blowing up fee budgets.
From a risk management standpoint, the portfolio's concentration is a double-edged sword. With 40.9% of the fund locked up in its top 10 holdings, we've noticed tangible payout volatility, including a recent 10% annual drop in its dividend rate from $1.37 to $1.23. While the 1.23% SEC yield and 1.91% TTM yield might look stable quarter-to-quarter at $0.1836 per share, income-focused allocators need to be fully aware that concentration-driven payout fluctuations can disrupt cash-flow projections.
As a quant researcher building multi-factor backtests, QVMT's triple filter—targeting high return on equity, low price-to-book, and twelve-month price momentum across 100 SandP 500 stocks—creates a distinctive profile. Over the past three years, this configuration returned 38% compared to IVV's 33%, primarily because it successfully underweight mega-cap tech names like Microsoft and avoided heavy Nvidia concentrations while maintaining a 24% TTM P/E discount.
In evaluating portfolio overlays, I emphasize that QVMT is fundamentally a structural departure from traditional market-cap weighting. By substituting mega-cap tech risk with a heavier loading in financials and energy names selected via rigorous QVM metrics, it functions as a potent hedge during market rotations away from concentrated growth leadership—provided investors can stomach the underlying stock concentration.
As an options desk strategist, I note that liquidity remains a primary constraint for larger institutional blocks given the fund's $133M asset base and 31% annual turnover. However, for retail and mid-sized wealth accounts looking for a smart complement to standard SandP 500 index ETFs, the low tracking error relative to non-backtested index data over the last decade offers a reliable blueprint for factor-based diversification.
Explore plasma cleansing, somatic organ swaps, and BCI.